Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy.
about
Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma.Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study.Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatmentHepatitis B reactivation and rituximab in the oncology practice.Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxisHepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapyHepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategiesA fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier.Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis.Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation.Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy.The metabolic regulator PGC-1α links anti-cancer cytotoxic chemotherapy to reactivation of hepatitis B virus.Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus antigens in patients with Epstein-Barr virus-negative Hodgkin's disease.A case of lamivudine-sensitive de novo acute hepatitis B induced by rituximab with the CHOP regimen for diffuse large B cell lymphoma.Hepatitis B virus reactivation and alemtuzumab therapy.Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues.Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation.
P2860
Q30434625-3A30DEF1-D8DE-4644-B04F-DBA6E4110A50Q33330483-0C9D62FA-D070-480A-BB65-ABA4D78E6333Q33619636-6289DF3A-3E20-4A27-8378-7D1937BA37B4Q34685836-29ED55EF-86DE-4D27-92FF-D8F9C723C4F7Q35583718-6EAD3C01-358C-4E2F-9B3E-605E66CB02D1Q35596827-1CD8A943-5D86-4BD8-9A28-02754D628BBFQ35597892-D400B473-809A-44F9-91B6-33BD4CB95208Q35637506-215CFEB1-21D1-4F75-91FF-854C6A00F312Q36154001-C1597B19-4222-4377-9A59-7DA12E6C568EQ36367268-E9659666-DF84-46E9-80DA-7006CC33E8E5Q36597776-9A74675E-3B86-45F1-A8B5-B74AF2A3462FQ36957087-2B9D56A6-D776-417C-9C8A-864A95B8E165Q37124256-3697EE5E-6FC2-4725-B638-8274A5220EDFQ37912229-74C77550-33DC-4BC0-9ADA-FB4920F45423Q38224439-B8AA2D20-A67B-4F1B-BFDF-3A4712B29734Q39227989-837582B9-0AC1-49A5-9A00-04C3ABFC51ABQ41500928-81EA9101-094F-4582-A09C-BDD4486A6BC4Q41903170-BBC253FC-2902-4786-B511-AA4EA9386B69Q45252401-1344603C-74C1-4AF9-8AD3-4D90B66E13AFQ45401512-C364B7E0-0525-4949-8B2A-266FE5451E76Q45412287-D56A84D7-774B-41B2-8E9B-2DD9673A1E46Q45413414-093881BB-AF6E-4E1D-B8F7-A73ABB52F8E0Q45420325-8F15B052-E8E5-4AF5-87F5-305B5D03D00A
P2860
Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Prophylaxis with lamivudine of ...... ias treated with chemotherapy.
@ast
Prophylaxis with lamivudine of ...... ias treated with chemotherapy.
@en
type
label
Prophylaxis with lamivudine of ...... ias treated with chemotherapy.
@ast
Prophylaxis with lamivudine of ...... ias treated with chemotherapy.
@en
prefLabel
Prophylaxis with lamivudine of ...... ias treated with chemotherapy.
@ast
Prophylaxis with lamivudine of ...... ias treated with chemotherapy.
@en
P2860
P1433
P1476
Prophylaxis with lamivudine of ...... ias treated with chemotherapy.
@en
P2093
Giuseppe Rossi
P2860
P304
P356
10.1080/104281903100006351
P577
2003-05-01T00:00:00Z